Preparing For Your APPOINTMENT
We look forward to meeting you on your first visit at Mary Crowley Cancer Research. To assist in your visit preparation, we have provided information that will help acquaint you with our program and hopefully make it easier for you and your family.
To Get You Started
You have the opportunity below, to print, complete and bring with you, necessary forms for your initial consultation visit. Additionally, our staff has provided you a step-by-step information document that describes all the different steps that will occur during you cancer journey at Mary Crowley. Lastly, if you have not already had your cancer molecular profile completed, read below about this test and how vital it is to matching you to the most appropriate clinical trial.
Forms and Information
Patient Intake Forms
At Mary Crowley Cancer Research, we believe that your health information is personal. We keep records of the care and services that you receive at our facilities. We are committed to keeping your health information private, and we are also required by law to respect your confidentiality.
Please click below for a copy of the Notice of Privacy Practices:
For more information about your health information privacy rights, click HERE.
Patient Molecular Testing
MOLECULAR TESTING: ROADMAP TO CANCER
Most people agree that using a Google™ map or similar navigation device ensures that a traveler will reach their destination accurately and more quickly than without such guidance. Next Generation Genomic Sequencing (NGS) represents the current, state-of-the-art molecular test and works like a roadmap for physicians and their cancer patients.
Molecular testing through NGS is routinely ordered for each patient at Mary Crowley that has a tissue sample of their tumor from an earlier surgery. The results identify the gene alterations/biomarkers that contribute to the patient’s cancer growth and act as a roadblock to traditional cancer treatments. Identification of gene mutations is valuable for the physician, but only with accurate interpretation and correlated therapies that address the molecular signature of the patient. With this information, a patient can be appropriately aligned to a matching therapy designed to impact that mutation or cancer signal (see below for an example of how this works in a Foundation One™ partial report).
All patient sequencing results are maintained in a dynamic Patient Molecular Registry at Mary Crowley and regularly assessed for a potential clinical trial match. Additionally, any patient may request Mary Crowley to conduct NGS of a portion of their surgical tumor in the event they may need a research option, if needed, after their initial cancer surgery and standard treatment.